Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 24;10(11):2274.
doi: 10.3390/jcm10112274.

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020

Affiliations

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020

Thomas Theo Brehm et al. J Clin Med. .

Abstract

In this study, we directly compared coronavirus disease 2019 (COVID-19) patients hospitalized during the first (27 February-28 July 2020) and second (29 July-31 December 2020) wave of the pandemic at a large tertiary center in northern Germany. Patients who presented during the first (n = 174) and second (n = 331) wave did not differ in age (median [IQR], 59 years [46, 71] vs. 58 years [42, 73]; p = 0.82) or age-adjusted Charlson Comorbidity Index (median [IQR], 2 [1, 4] vs. 2 [0, 4]; p = 0.50). During the second wave, a higher proportion of patients were treated as outpatients (11% [n = 20] vs. 20% [n = 67]), fewer patients were admitted to the intensive care unit (43% [n = 75] vs. 29% [n = 96]), and duration of hospitalization was significantly shorter (median days [IQR], 14 [8, 34] vs. 11 [5, 19]; p < 0.001). However, in-hospital mortality was high throughout the pandemic and did not differ between the two periods (16% [n = 27] vs. 16% [n = 54]; p = 0.89). While novel treatment strategies and increased knowledge about the clinical management of COVID-19 may have resulted in a less severe disease course in some patients, in-hospital mortality remained unaltered at a high level. These findings highlight the unabated need for efforts to hamper severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) transmission, to increase vaccination coverage, and to develop novel treatment strategies to prevent mortality and decrease morbidity.

Keywords: COVID-19; SARS-CoV-2; first wave; hospital; mortality; patients; second wave; treatment.

PubMed Disclaimer

Conflict of interest statement

A.N. declares that he received lecture honoraria and travel reimbursement over the past five years from CytoSorbents Europe, Biotest AG, and ThermoFisher Scientific. S.K. declares that he has received personal fees for lectures or consultancy and/or research support from Ambu, Astra Zeneca, Bard, Baxter, Bayer, Biotest, CytoSorbents, Daiichi Sankyo, E.T.ViewLtd, Fisher & Paykel, Fresenius Medical Care, Gilead, Mitsubishi Tanabe, MSD, Pfizer, Philips, Xenios, and Zoll. The authors declare they have no competing financial interest.

Figures

Figure 1
Figure 1
The numbers of COVID-19 patients newly admitted to our hospital or seen as outpatients in our emergency department are listed for each month. The dotted line represents the border between the first and the second wave (29 July 2020).
Figure 2
Figure 2
(a) Sex distribution, (b) disease severity, and (c) and in-hospital mortality of COVID-19 patients at our center during the first wave (left) and second wave (right) of the pandemic stratified by age group.
Figure 3
Figure 3
The proportion of patients discharged alive during the first and second waves compared by the log-rank test.

Similar articles

Cited by

References

    1. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. [(accessed on 23 April 2021)]; Available online: https://www.who.int/director-general/speeches/detail/who-director-genera....
    1. Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020;382:970–971. doi: 10.1056/NEJMc2001468. - DOI - PMC - PubMed
    1. Pfefferle S., Günther T., Kobbe R., Czech-Sioli M., Nörz D., Santer R., Oh J., Kluge S., Oestereich L., Peldschus K., et al. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany. Clin. Microbiol. Infect. 2021;27:130.e5–130.e8. doi: 10.1016/j.cmi.2020.09.034. - DOI - PMC - PubMed
    1. Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute 10/04/2020—Updated Status for Germany. [(accessed on 23 April 2021)]; Available online: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsb....
    1. Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute. 31/12/2020—Updated Status for Germany. [(accessed on 23 April 2021)]; Available online: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsb....

LinkOut - more resources